INS and Cognitive impairment: Furthermore, it has long been established that molecular interactions between pathological proteins may occur within the same brain in various distribution patterns, causing variable phenotypes and mixed pathologies, and so it is possible that T2DM, via dysregulated insulin signaling, may lead to promotion of AD pathology in a subset of patients with PD, increasing the risk of developing cognitive impairment.